Cryosite Limited (ASX:CTE)

Market Cap	36.36M
Revenue (ttm)	12.85M
Net Income (ttm)	1.83M
Shares Out	48.81M
EPS (ttm)	0.04
PE Ratio	19.85
Forward PE	n/a
Dividend	0.02 (2.68%)
Ex-Dividend Date	n/a

Volume	2,465
Average Volume	458
Open	0.7450
Previous Close	0.7450
Day's Range	0.7450 - 0.7450
52-Week Range	0.6720 - 1.2500
Beta	0.35
RSI	43.72
Earnings Date	May 21, 2025

About Cryosite

Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through two segments: Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment offers specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological, and cell gene therapies depot services. The Cord Blood and Tissues Storage segment provides long term storage...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 25
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CTE

Financial Performance

In 2024, Cryosite's revenue was 12.61 million, an increase of 5.67% compared to the previous year's 11.94 million. Earnings were 1.84 million, an increase of 30.59%.